emb07
Relapse/Refractory Lymphoma
EpimAb Biotherapeutics (Suzhou)Co., Ltd.Phase 1
—
Rating in progress
emb07 in Relapse/Refractory Lymphoma is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Active